Articles

Lilly committed to China despite IP woes

Indianapolis-based Eli Lilly and Co. is one of several Western pharmaceutical firms that see China as a linchpin of growth in coming years, due to patent expirations and a slowdown in government reimbursements for prescription medicines in the U.S. and European markets.

Read More

Critics: Patent overhaul could hurt startups

When the Senate passed legislation last week overhauling the U.S. patent system, large multinational corporations like Eli Lilly and Co. rejoiced. But small-business advocates cried foul, saying the changes would put innovative startups at a disadvantage.

Read More

Purdue steps up efforts to halt illegal downloads

The Higher Education Opportunity Act requires schools to fight illegal distribution of copyrighted material and educate campus
communities about the issue. Schools that don’t comply risk losing their eligibility for federal student aid.

Read More